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Abstract: The bacterial species Neisseria gonorrhoeae (N. gonorrhoeae) and Staphylococcus aureus
(S. aureus) are amongst the main microorganisms that cause ophthalmia neonatorum. The current
treatment involves the use of various antibiotics such as ciprofloxacin, cephalosporin, ceftriaxone
and cefotaxime. However, this treatment strategy is becoming more ineffective due to the antibiotic
resistance in N. gonorrhoeae. The current study explores the potential use of fatty acid based
microemulsions (ME) to prevent N. gonorrhoeae and S. aureus infections in new-borns’ eyes without
harmful side effects such as corneal or conjunctiva irritation. Pseudo-ternary phase diagrams
were constructed to evaluate microemulsion regions and six different α-linolenic acid based
microemulsions were prepared. The prepared formulations were characterized for α-linolenic acid
content, size, transparency, zeta potential, Polarized light Microscopy, antimicrobial activity and
ex vivo ocular toxicity. The mean droplet size of the ME formulations was in the range of 190.4 to
350.5 nm and polydispersity index (PDI) values were in the range of 0.102 to 0.561. All formulations
were found stable upon storage for at least 8 weeks. In addition, self-diffusion coefficients determined
by nuclear magnetic resonance (NMR) reflected that the diffusability of water increased at higher
than 30% w/w water, while that of fatty acids and surfactants was in reverse. The antimicrobial
efficacy of microemulsions was determined against N. gonorrhoeae and S. aureus. It was concluded
that all microemulsions have strong antimicrobial effects against N. gonorrhoeae and S. aureus. Finally,
bovine corneal opacity permeability (BCOP) and hen’s egg chorioallantoic (HET-CAM) tests results
showed that all microemulsion formulations were not strong ocular irritants.
Keywords: fatty acid; ophthalmia neonatorum; microemulsion; pseudo-ternary phase diagram;
ocular toxicity/irritation potential
1. Introduction
Ophthalmia neonatorum is a form of conjunctivitis in new-borns, usually contracted during
birth from passage through the infected birth canal of the mother [1]. The bacterial species
Neisseria gonorrhoeae is the cause of the sexually transmitted disease gonorrhoea [2] and the cause of
ophthalmia neonatorum. Neisseria gonorrhoeae (N. gonorrhoeae) accounts for 30% to 45% of ophthalmia
cases [3,4]. Nonsexually transmitted bacteria, such as Staphylococcus aureus (S. aureus), can also cause
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neonatal conjunctivitis. S. aureus accounts for 30% to 50% cases of ophthalmia neonatorum [3,4].
N. gonorrhoeae infection is of particular concern as it cannot be successfully treated, it can cause corneal
ulceration and perforation of the globe of the eye, which can rapidly lead to blindness. If left untreated,
the neonatal bacterial eye infections can potentially spread, causing life threatening conditions such
as septicaemia and meningitis. Opthalmia neonatorum occurs in 1% to 12% of new-born infants and
leads to blindness in approximately 10,000 babies annually worldwide [5].
There are a variety of treatments that can be used against gonococcal ophthalmia neonatorum
(GCON). Control strategies include the treatment of gonococcal infection in pregnant women, diagnosis
and treatment of GCON and eye prophylaxis in the new born at birth. The treatment of gonococcal
infections in pregnant women requires screening and is expensive [5]. Eye prophylaxis by the
instillation of 1% silver nitrate in the first h of life is not always possible and no longer in use as
silver nitrate is toxic and causes chemical conjunctivitis [6,7]. Recently, various antibiotics such
as ceftriaxone IV or IM and cefotaxime IM are recommended as first line therapy for gonococcal
ophthalmia neonatorum and other gonococcal infections in the new born [8,9]. However, in the
last few years, mutants of gonococci expressing significant resistance to these antibiotics have been
identified worldwide [10,11].
It has been proposed that a fatty acid based eye formulation can be used as an alternative
control strategy [8]. Several fatty acids have a broad spectrum of microbicidal activity against
enveloped viruses and various Gram positive and Gram negative bacteria, including N. gonorrhoeae
and S. aureus [8,12]. In recent years, microbicidal effects of medium- and long-chain fatty acids and
their corresponding 1-monoglycerides have been studied. They have been found to have a broad
spectrum of microbicidal activity against enveloped viruses and various bacteria in vitro, including
pathogens such as herpes simplex virus (HSV), Neisseria gonorrhoea and Chlamydia trachomati [8,12].
Nearly 10 years ago, the bactericidal potencies of saturated and unsaturated fatty acids and
monoglycerides (MGs) against Helicobacter pylori were determined following short incubations with
freshly harvested cells over a range of pHs. Lauric acid was found to kill the bacterial species at a
minimum bactericidal concentration (MBC) of 1 mM at pH 7.4, myristoleic and linolenic acid were
found to be potent at MBC of 0.5 mM at pH 7.4 and monolaurin was found to be the most potent
monoglyceride (MBC 0.5 mM). The bactericidal potencies of unsaturated fatty acids were found to
increase with degree of unsaturation [13]. It has been found that N. gonorrhoeae is highly susceptible
to lauric acid (C12:0), myristic acid (C14:0), oleic acid (C18:1), linoleic acid (C18:2), linolenic acid
(C18:3) and arachidonic acid (C20:4) but is resistant to straight-chain, saturated fatty acids with
18 or more carbons [14]. Various long-chain polyunsaturated fatty acids (LC-PUFAs)—including
eicosapentaenoic acid (EPA; C20:5n-3), docosahexaenoic acid (DHA; C22:6n-3), γ-linolenic acid (GLA;
C18:3n-6) and dihomo-γ-linolenic acid (DGLA; C20:3n-6)—have shown to exert highly potent activity
against S. aureus [15]. In 1990, Bergsson et al. tested several fatty acids and their 1-monoglycerides for
their microbicidal activities against N. gonorrhoea at a short inactivation time of 1 min. It was shown that
1 min exposure to 2.5 mM lauric acid and monocaprin—a monoglyceride of capric acid—causes the
fastest and most effective killing of all strains of N. gonorrhoea tested [8]. Over ten years ago, a hydrogel
containing 10 mM monocaprin was found to kill high titres of N. gonorrhoea within 1 minute [16].
Although many studies looked at the microbial effects of fatty acids on various microbes, no studies
evaluated the effect of fatty acid formulations on bacteria, fungi or viruses.
In the present study, a fatty acid based microemulsions were prepared. α-linolenic acid
was selected because of its significant antimicrobial activity against N. gonorrhoeae and S. aureus
as per our previous studies [17,18]. The prepared microemulsions (ME) formulations were
characterized by polarized light microscopy and self-diffusion NMR (Nuclear magnetic resonance).
Different pharmaceutical formulation properties such as clarity, pH, particle size, viscosity, physical
and chemical stability and sterility of the formulations were investigated as part of the development
phase of an eye formulation. In addition, antibacterial activity of the α-linolenic acid-based ME
was tested against N. gonorrhoeae and S. aureus. Finally, the eye formulations were tested for ocular
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toxicity/irritation potential using the bovine corneal opacity and permeability (BCOP) test and the
hens egg chorioallantoic membrane test (HET-CAM). The estimated costs for routine neonatal ocular
prophylaxis are $7.7 per child and $1.94 for treatment using erythromycin. Nonetheless the costs will
increase with the development of resistance to the current antibiotics used for treatment of ophthalmia
neonatorum conditions. The use of fatty acids can minimize the costs associated with the antimicrobial
resistance [19].
2. Results and Discussion
2.1. Saturation Solubility
Absorbance was measured by UV spectrophotometer at 350 nm to determine the solubility of
α-linolenic acid in various surfactants. The correlation between concentration (mg/mL) and absorbance
(average of 3 determinations) was plotted to find out saturation point of a compound. It was found
that all excipients were able to dissolve α-linolenic acid, although not to the same extent.
Solubility of α-linolenic acid in different excipients is summarized in Figure 1A. The results of
saturation solubility studies revealed that α-linolenic acid has high solubility in Cremophor EL and
Tween 80 as compared to Tween 20, Labrasol, Labrafil M2125 and Caproyl 90. Amongst the tested
co-surfactants, Transcutol P and PEG 400 solubilized α-linolenic acid the most. Therefore, Tween
80 and Cremophor EL were selected as surfactants and Transcutol P and PEG 400 were selected as
cosurfactants, respectively, for the phase behaviour study.
Figure 1. Saturation solubility of α-linolenic acid in different surfactant (A) and different ratios of
surfactants blends (B). Mean ± SD, n = 3.
The solubility profile of α-linolenic acid in the selected surfactant/co-surfactant blends as shown
in Figure 1B reveals that α-linolenic acid had the highest solubility in Tween 80/Transcutol P mixture
compared with Cremophor EL/Transcutol P.
The high solubility of α-linolenic acid in Tween 80 and Cremophor EL could be due to the
structural similarities between α-linolenic acid, Tween 80 and Cremophor EL. α-linolenic acid is a long
chain (C18) of unsaturated fatty acid. Tween 80 is structurally composed of polyoxyethylene sorbitan
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(head group) and unsaturated oleic acid (tail group). Tween 80 shares a carbon chain tail of similar
length (C18) to α-linolenic acid.
Cremophor EL head portion consists of polyethylene glycols and glycerol ethoxylates, whereas
the tail portion is composed of oxyethylated triglycerides of a long chain (C18) unsaturated ricinoleic
acid, which is structurally similar to the long chain (C18) of unsaturated α-linolenic acid.
Both Tween 80 and Cremophor EL have a hydrophobic tail of similar length (C18) to α-linolenic
acid. It is possible that these hydrophobic chains were responsible for increasing the solubility profile
for α-linolenic acid. Both Tween 80 (Hydrophilic-Lipophilic Balance; HLB = 15) and Cremophor
EL (HLB = 14) have high hydrophilic nature and good emulsion forming capacity due to their
high HLB values. However, α-linolenic acid solubility was higher in Cremphor EL as compared to
Tween 80. This could be because Tween 80 consists of a single chain of oleic acid as lipophilic part
while Cremophore EL has three fatty acid chains attached to PEG-glycerol. This bulkier lipophilic part
enhances the emulsification properties of Cremophore EL [20]. Nonetheless, Tween 20 (HLB = 16.7)
showed low solubility capacity despite having high HLB value. This could be due the different
hydrophobic tail group, which is composed of saturated medium-chain lauric acid (C12). These results
are in agreement with the results of the previous study conducted by Mosca et al. [21] and show that
the length and size of the hydrophobic side chains of surfactants determines the interactions with the
oil phase [21]. Labrasol (HLB = 12), labrafil M2125 (HLB = 4) and Caproyl 90 (HLB = 6) showed the
lowest solubility enhancement for α-linolenic. This might be due to their low HLB values that cause
incompatibility between these hydrophilic surfactants and α-linolenic acid.
Based on saturation solubility studies, Transcutol P was selected as co-surfactant because
α-linolenic acid showed good solubility in this solvent. A blend of surfactants and co-surfactant
is needed to increase drug solubility and to obtain a stable microemulsion [22]. These co-surfactants
help to further reduce the surface tension and fluidize the surfactant film, which increases the entropy
of the system leading to its thermodynamic stability. Co-surfactants also increase the flexibility of the
interfacial film around the microemulsion droplet [23,24].
It is known that a single surfactant is not sufficient to form balanced microemulsions
and a combination of surfactant and co-surfactant is required to optimize the formation of a
microemulsion [25]. Therefore, the selection of surfactant/co-surfactant blends is important in the
formulation of a stable dispersion system.
The selected surfactants were blended with the selected co-surfactant in ratios of 1:1, 1:4 and
4:1 (w/w). Among the surfactant/co-surfactant blends, two mixtures had the highest solubilisation
capacities for α-linolenic acid: Tween 80/Transcutol P 1:1 (w/w) and Cremophor EL/Transcutol
P 4:1 (w/w). Thus, these two blends were selected to study the phase behaviour of α-linolenic acid.
2.2. Construction of Pseudo-Ternary Phase Diagrams
The pseudo-ternary phase diagrams were constructed using phase diagram by micro-plate
dilution (PDMPD) method. Ternary phase diagrams were constructed by taking 1:1 ratio of
Tween 80/Transcutol P and 4:1 ratio of Cremophor EL/Transcutol P. The shaded area of the
phase diagrams shows the ME region, whereas the non-shaded area displays the none ME region.
The pseudo-ternary phase diagrams of the α-linolenic acid/surfactant:co-surfactant/water are shown
in Figure 2. The phase behaviour study revealed that the emulsion region was larger with 1:1 Tween
80/Transcutol P (Figure 2A) in comparison with Cremophor EL/Transcutol P (Figure 2B). From the
phase diagrams, it can be observed that ME regions increase with increasing surfactant:co-surfactant
mix ratio. This could be due to the effect of the hydrophilic co-solvents and/or co-surfactants that
reduce the interfacial tension and increase the fluidity of the oil-water interface and hence, promoted
the formation of microemulsions [23,24].
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Figure 2. Pseudo-ternary phase diagrams of α-linolenic acid, water, surfactant/cosurfactant (S/CoS)
mix made of (A) Tween 80/Transcutol P (1:1), (B) Cremophor EL/Transcutol P (4:1).
2.3. Preparation and Characterization of Microemulsions
Formulations were developed based on the microemulsion zone of pseudo-ternary phase diagrams.
The composition of selected ME formulations is given in Table 1. All the developed formulations
were found to be clear/transparent on visual inspection. The clarity of microemulsions was also
checked by transparency, measured as percent transmittance (%T). All ME formulations showed %
transmittance value greater than 98% (Table 1). These results indicate t that these compositions are
isotropic one-phase systems.
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Table 1. Composition and characterisation criteria of the selected microemulsion formulations, fatty acid microemulsions were characterised for their particle size
(nm), zeta potential (mV), light transmittance (%), viscosity (mPa·S) and contact angle (θ). Data is presented as mean ± standard deviation (SD), where n = 3.
Formulation
Composition
Particle Size
± SD (nm) PDI± SD
Zeta
Potential
(mV)
%
Transmittance
(at 600 nm)
pH
Viscosity
(mPa·S)
α-Linolenic
Acid
Content
%
Contact
Angle on
Hydrophilic
Surface (
◦
)
Contact
Angle on
Hydrophobic
Surface (
◦
)
Fatty Acid
(FA)% S/CoS% Water%
T1 (Tween80/Transcutol P) 4 88 8 190.4 ± 2.3 0.309 ± 0.12 0.124 ± 0.022 98% 5.96 ± 0.02 65.32 ± 2.15 92.5 14.1 ± 0.85 29.5 ± 2.43
T2 (Tween8/Transcutol P) 6 60 34 205.1 ± 1.2 0.551 ± 0.085 0.107 ± 0.014 98% 4.66 ± 0.01 96.12 ± 4.22 95.9 12.2 ± 0.06 35.2 ± 3.73
T3 (Tween8/Transcutol P) 35 60 5 219.1 ± 1.5 0.383 ± 0.056 0.394 ± 0.035 115% 5.33 ± 0.02 56.67 ± 2.32 99.8 15.7 ± 2.51 25.9 ± 3.70
C1 (Cremophor
EL/Transcutol P) 4 86 10 340.1 ± 1.9 0.561 ± 0.032 0.025 ± 0.011 99% 6.23 ± 0.02 82.53 ± 1.63 91.8 25.1 ± 2.41 34.8 ± 3.08
C2 (Cremophor
EL/Transcutol P) 6 62 32 225.6 ± 2.1 0.392 ± 0.14 0.303 ± 0.054 98% 5.43 ± 0.01
101.42 ±
3.11 93.3 16.2 ± 3.36 43.8 ± 4.30
C3 (Cremophor
EL/Transcutol P) 35 60 5 246.4 ± 3.3 0.484 ± 0.025 0.102 ± 0.012 97% 5.47 ± 0.02 74.46 ± 2.56 96.4 25.2 ± 2.60 38.0 ± 5.68
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2.3.1. Characterization of Microemulsions
Polarized light microscopy can distinguish between isotropic and anisotropic materials. The ME
samples containing water/surfactant:co-surfactant/oil were examined under polarized light for sample
anisotropy and birefringence. The binary systems containing only water/surfactant were also observed
under polarized light. The ME samples did not show any birefringence and appeared completely
dark under polarized light (Figure 3C) characteristic of isotropic material. On the other hand, textures
characteristic of lyotropic lamellar liquid crystals (were seen with water/surfactant micrographs as
shown in Figure 3A,B. These observations indicate that all the ME formulations were optically isotropic
colloidal dispersions.
Figure 3. Photomicrographs of samples under polarized light microscopy (A) Lamellar liquid crystals
of Tween 80/water, (B) Lamellar liquid crystals of Cremophor EL/water, (C) Microemulsion.
The droplet size plays a significant role in the microemulsion stability and performance because it
determines the rate and extent of drug release as well as in vivo absorption. It has been reported that
the smaller droplet size of the emulsion provides better drug absorption by increasing the interfacial
area in contact with biological membranes [26,27]. Table 1 shows the results of particle size analysis,
polydispersity index (PDI) and zeta potential of prepared microemulsions. All ME formulations
showed an average droplet size of more than 200 nm except T1 which showed the smallest droplet
size of 190.4 ± 2.31 nm. The overall higher droplet size could be due to the fact that both surfactants
used in ME formulations, Tween 80 and Cremophor EL, have alkyl carbon chain lengths of 18, which
is similar to the long chain (C18) of unsaturated α-linolenic acid (oil). This finding was consistent
with a previous study which reported that oil with carbon chain length similar to that of surfactant
increases the average droplet size [28–30]. The PDI value for all formulations was less than 1 which
is desirable (Table 1). The lower PDI value indicates a higher uniformity of the droplet size in the
formulation [31]. Zeta potential is related to the stability of colloidal dispersions. Zeta potential
indicates the degree of repulsion between adjacent, similarly charged particles in dispersion. When the
zeta potential value is high, the electrostatic repulsive forces between the droplets increase which
prevents the coalescence of the droplets. So, colloids with high zeta potential (negative or positive)
are electrically stabilized [32,33]. The mean zeta potential value of the prepared microemulsions was
consistently negative and ranged between−0.025± 0.011 and−0.394± 0.035 mV, which was generally
of smaller magnitude (Table 1). These low zeta potential values could be due to the larger droplet sizes.
The use of non-ionic surfactants, Tween 80 and Cremophor EL also lowers the zeta potential values [34].
Negative zeta potential measurements indicate that the interface is negatively charged. This negative
charge imparts stability to the ME system by producing electrostatic repulsive forces of head groups
which thereby hindering aggregation with nearby droplets [35].
The pH values of all ME formulations are given in Table 1. The pH of all ME formulation
ranged between 4.66 and 6.23, which is within the normal pH range of marketed ophthalmic solutions.
The normal pH value is one of the formulation considerations that may help reducing the eye irritation
produced upon instillation.
All microemulsion samples were found to have viscosities in the range of 56 to 101 mPa·S.
Table 1 gives the viscosity measurements for all ME formulations. These results indicate that
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formulation C2 showed the highest viscosity. It was observed that there was an increase in viscosity
with an increase in the water content and surfactant:co-surfactant ratio.
The drug content in the ME formulations was measured using the previously published
Gas-chromatography (GC) method [17]. The percent drug content of all ME formulations is shown
in Table 1. The amount of the FA in all ME formulations ranged from 92% to 99% of the original
amount which indicates that the FA is stable when loaded into these ME systems.
To evaluate the stability of the selected ME formulations, they were kept at different temperatures
(4 ◦C, 25 ◦C and 40 ◦C) for 8 weeks and were evaluated periodically. Results of stability studies
indicated that after 8 weeks, there were no significant changes (p value > 0.05) in the initial droplet
size and drug content of the microemulsions stored at 4 ◦C and 25 ◦C and there were no sign of
phase separation or drug precipitation on storage. However, slight changes were observed in the
initial droplet size and drug content of the microemulsions stored at 40 ◦C. This might be due to the
oxidative degradation of the linolenic acid in the MEs at higher temperatures as suggested earlier
by [36]. The results are shown in Figures 4 and 5. Earlier reports [37] suggested the autoxidation of
linolenic acid into hydroperoxides at carbon 9, 12, 13 and 16. Also secondary oxidation products such
as propanal, 2-butenal and 2-pentenal were reported. The relative autoxidation rate of linolenic acid
ranges between 1:40 and 50:100 according to the oxygen update [37]. According the current results it is
evident that the stability of linolenic acid in the microemulsion formulations is high. Possibly the ME
formulations reduced the oxygen contact with the fatty acid, hence protected the FA from degradation
caused by autoxidation.
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2.3.2. Contact Angle easure ents
Therapeutic activity of the ophthal ic icroe ulsions depends on the extent to which the fluid
wets and covers the corneal surface. Spreading is a fundamental phenomenon in which the fluid phase
is displaced completely or partially on the surface of a solid. One of the most useful parameters that is
typically used to describe spreading and wetting properties of ophthalmic MEs is the contact angle
of the liquid on the hydrophilic corneal surface [38]. The surface of the cornea is typically covered
with a hydrophilic mucoid or mucin layer of the tear film to transform the hydrophobic corneal
surface into a hydrophilic surface [39]. Therefore, an ophthalmic microemulsion needs to both wet and
spread on the corneal surface and then penetrate to maximize the therapeutic activity. The contact
angle depends on surface tension of the liquid, surface free energy (interfacial tension between the
liquid and the solid) and the interaction forces between the liquid and solid surface and between the
liquid molecules themselves. If adhesive forces between the solid surface and the liquid are stronger,
the droplet will completely spread out on the solid surface resulting in smaller contact angle. If the
cohesive forces within the liquid drop (i.e. hydrogen bonds and Van der Waals forces) are stronger,
the droplet will avoid contact with the solid surface resulting in larger contact angle [40]. If the contact
angle is low, the fluid will spread to cover or “wet” a larger area of the surface. If the contact angle is
high, the fluid will form a compact, self-contained droplet on the surface [41]. The results of contact
angle measurements are given in Table 1. The contact angle of all ME formulations ranged from 12.2◦
to 25.2◦ on hydrophilic surface and from 25.9◦ to 43.8◦ on hydrophobic surface. These results indicate
that all MEs had relatively low contact angle demonstrating good spreading ability. These results
also revealed that all MEs possessed larger contact angle on hydrophobic surface as compared to
hydrophilic surface. This could be due to the fact that interfacial tension is high on a hydrophilic
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surface and low on a hydrophobic surface. The high interfacial tension causes low interaction between
the hydrophobic solid surface and ME droplet (low surface energy) which results in high contact angle,
hence the poor spreading ability.
Overall results indicate that contact angle values for all MEs did not exceeded 90◦ on both
hydrophilic and hydrophobic surfaces (Table 1), confirming that all MEs have the ability to cover and
wet the ocular surface which could potentially translate to increased therapeutic effect.
2.3.3. Self-Diffusion NMR
Self-diffusion NMR spectroscopy (DOSY) is a powerful technique for characterisation of
microemulsion structures. It is used to distinguish between bicontinuous and droplet type
microemulsions [42,43]. It utilizes apparent translational diffusion coefficients in characterizing the
microemulsions [44,45]. The diffusion coefficients (D) were obtained from the slope of the equation:
ln
(
Ig
I0
)
= −[γ 2g2δ2
(
∆− δ
3
)
]D (1)
The characteristic NMR peaks for fatty acid (α-linolenic acid), surfactants (Tween 80 and
Cremophor EL), Transcutol P and water. The proton signal of the terminal methyl group of fatty
acid, surfactants and Transcutol P appeared at around 1.02 ppm, 0.95 ppm and 1.25 ppm, respectively,
whereas a small peak at approximately 4.7 ppm assigned to water.
The self-diffusion coefficients of fatty acid, surfactants (Tween 80 and Cremophor EL), Transcutol
P and water in ME systems were around 10−1 m2/s as shown in Figure 6A,B. These low self-diffusion
coefficient values indicate that the bicontinuous microemulsions were not likely to have formed.
The self-diffusion coefficients of pure components were also calculated as shown in Figure 6A,B.
Then the self-diffusion coefficient values of components in all ME samples were compared with that of
the pure component to determine the microemulsion type [42,43].
If the ME system is of a droplet-type, the self-diffusion of the components of the internal
pseudo-phase is determined by the diffusion of the droplet itself and therefore will be slower than
that of the pure components. In a bicontinuous microemulsion, where both oil and water are forming
larger domains, the diffusion of both components is high and of the same magnitude as that of the
pure components [42,43].
These results indicate that self-diffusion coefficients of fatty acid, surfactants, Transcutol P and
water in the MEs were lower than that of the pure components. These results suggest the formation of
droplet type microemulsions as there is no evidence on the presence of a bicontinuous microstructure
from the current NMR data. These results also indicate that the self-diffusion coefficient of fatty acid
and surfactants further decreased upon increase of water concentration. The self-diffusion coefficient
of water was higher than that of α-linolenic acid, Tween 80, Cremophor EL and Transcutol P in all
systems but a stronger increase in the water self-diffusion coefficient started at samples containing 30%
w/w of water or more. This suggests a possible change from water-in-oil to oil in water at this point.
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Figure 6. The self-diffusion coefficients of each component in α-Linolenic acid/water/Tween
80:Transcutol P(1:1) systems containing various concentrations of water from 0 to 50% (w/w) (A) and
each component in α-Linolenic acid/water/CR-EL:Transcutol P(4:1) systems containing various
concentrations of water from 0 to 50% (w/w) (B).
2.3.4. Bovine Corneal Opacity and Permeability (BCOP) Test
The bovine corneal opacity and permeability (BCOP) test measures changes in corneal opacity,
determined by changes in light transmission and permeability, measured by increases in permeability
to fluorescein, as a result of exposure to a test substance. The opacity and permeability values are
used to calculate an in vitro score, in order to reflect the ocular irritation potential [46]. This test is well
suited to identify substances moderately and severely irritating to the eye [47]. Figure 7 shows the
cumulative bovine eye test scores for the controls and test substances. Apart from Transcutol P and
formulation T1 and C1, the average cumulative scores calculated for individual components (Tween 80,
Cremophor EL and α-linolenic acid) and MEs (T2, T3, C2, C3) were found to be less than 0.5 (<0.5)
indicating that they are non-irritating. These test substances did not show any signs of corneal injuries
with no changes in corneal opacity, corneal permeability, or epithelial damage]. Transcutol P and ME
formulation T1 and C1 with an average cumulative score of 1.5, 0.8 and 0.8, respectively, indicated
minor irritation based on corneal opacity and fluorescein permeability.
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Figure 7. Cumulative BCOP scores of NaOH (strong positive control), Acetone (moderate positive
control), Normal Saline (negative control), Tween 80, Cremophor EL, Transcutol P, and the
microemulsion formulations; T1, T2, T3 and C1, C2 and C3. Results are expressed as mean values± SD, n = 3.
The healthy cornea is transparent and completely impermeable to fluorescein dye, due to the
exclusive tight junctions of the corneal epithelium. Figure 8 show photographs of corneal opacity and
fluorescein permeability for controls and test materials. These results showed that NaOH induced
marked opacity and complete fluorescein staining of cornea whereas saline (negative control) caused
no corneal opacity or staining as shown in Figure 8. Transcutol P caused slight irritation manifested as
weak corneal opacity and permeability. Two formulations (T1 and C1) also exhibited slight corneal
opacity and fluorescein staining which could be due to the high percentage of surfactant:co-surfactant
in T1 and C1 (88% and 86%, respectively). Overall, the tested formulaions did not cause any strong
corneal irritation signs and as such were regarded as safe to further test in live animals.
Figure 8. Degree of corneal opacity and fluorescein permeability for Tween 80, Cremophor EL,
Transcutol P, NaOH and the microemulsion formulations; T1, T2, T3 and C1.
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2.3.5. Hen’s Egg Test Chorioallantoic Membrane (HET-CAM)
The HET-CAM provides invaluable information on the conjunctival irritation potential of the
test substance. The CAM responds to injury with a complete inflammatory process similar to that
induced by the conjunctival tissue of the eye [46]. After the treatment, the surface of the CAM
was observed for any changes at different time points (after 30 s, 1 min, 2 min and 5 min) and the
average cumulative HET-CAM test scores for the controls and test materials were calculated (Figure 9).
The average cumulative scores calculated for individual components (Tween 80, Cremophor EL and
α-linolenic acid) and MEs (T2, C2, C3) were found to be less than 0.9 (<0.9). These results reveal that
these tested substances are practically non-irritant when applied to the surface of the CAM. In contrast,
Transcutol P and three ME formulation (T1, T3 and C1) showed slight irritant effects with an average
cumulative score of 4.6, 1.2, 1.4 and 1.1, respectively (Figure 9). The results of the ocular irritation of
Transcutol P are in agreement with the findings of Liu et al. who found that Transcutol P causes slight
irritation at a concentration of 0.05% without any visible ocular damage or abnormal clinical signs
involving the cornea, iris, or conjunctivae at all concentrations [48].
Figure 9. Cumulative HET-CAM scores of NaOH, Acetone, Normal Saline, Tween 80, Cremophor EL,
Transcutol P, and the microemulsion formulations; T1, T2, T3 and C1, C2 and C3. Results are expressed
as mean values ± SD, n = 3.
Figure 10 shows the effects induced by the tested formulations and the selected controls on the
surface of the CAM before and after treatment for 5 min of contact. These results showed that NaOH
(positive control) induced major damage and caused complete lysis and degradation of immature
blood vessels when applied to the surface of the CAM (Figure 10A), whereas the normal saline
showed no effect (Figure 10B). Transcutol P caused slight degradation of blood vessels (Figure 10C).
Three microemulsion formulations (T1, T3 and C1) developed minimal irritation potential manifested
as very slight lysis of blood vessels after 5 min as shown in Figure 10E–G) respectively. Overall, none
of the tested formulations caused any major damage to the blood vessels. These results indicate that all
of the tested formulations did not show strong irritant effect when applied to the surface of the CAM.
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Figure 10. Effect of controls and test substances on the surface of the chorioallantoic membrane
(CAM) after treatment for 5 min (A) NaOH, (B) Normal saline, (C) Transcutol P, (D) Tween 80,
(E) microemulsion (T1), (F) microemulsion (T2), (G) microemulsion (T3), (H) microemulsion (C1),
(I) microemulsion (C3), (J) microemulsion (C2).
2.3.6. Antibacterial Activity of Microemulsions against N. gonorrhoeae and S. aureus
In this study, the individual components (α-linolenic acid, Tween 80, Cremophor EL and
Trascutol P) and six formulated MEs were tested against N. gonorrhoeae and S. aureus (Table 2).
The results showed that both N. gonorrhoeae and S. aureus were susceptible to all ME formulations.
Fatty acids are known to kill or inhibit the growth of bacteria by disrupting cell membrane
which is caused by interference with the electron transport chain and the disruption of oxidative
phosphorylation. The electron transport chain is located in the inner membrane of bacterium and is
essential source of energy for bacterium. The disruption of electron transport chain is caused either
by directly binding of FAs to the electron carriers of the electron transport chain or by insertion into
the inner membrane so the ability of the electron transport chain to transfer electrons is impaired.
This result in reduced proton gradient and membrane potential which results in reduced ATP
production, an essential source of energy for bacterium. FAs may also inhibit the bacterial growth
by cell lysis, inhibition of enzyme activity, impairment of nutrient uptake and the generation of
toxic peroxidation and autoxidation products [49]. Among the individual components Tween 80,
Cremophor EL and Transcutol P exhibited antibacterial activity against only S. aureus. These results
also indicate that T3 (35% α-linolenic acid and 60% surfactant:co-surfactant) and C3 (35% α-linolenic
acid and 60% surfactant:co-surfactant) exhibited the larges antibacterial zones of inhibition against both
microbial agents compared to other formulations. T1, T2, C1 and C2 showed medium antibacterial zone
against S. aureus whereas these MEs showed lowest antibacterial zone against N. gonorrhoeae. Overall,
all ME formulations showed strong inhibitory effect against S. aureus compared to N. gonorrhoeae.
This might be due to the fact that all excipients (Tween 80, Cremophor EL, Transcutol P) showed strong
antimicrobial effect against S. aureus compared to N. gonorrhoeae.
Table 2. Growth inhibition zone diameter of three selected α-linolenic acid based ME formulations and
individual components against N. gonorrhoeae and S. aureus mean ± SD% (n = 3).
Formulation Zone of Inhibition against N. gonorrhoeae Zone of Inhibition against S. aureus
T1 6.5 ± 0.7 mm 14.5 ± 0.7 mm
T2 8.5 ± 0.7 mm 15 ± 1.00 mm
T3 22 ± 1.00 mm 21.5 ± 0.7 mm
C1 6.75 ± 0.4 mm 17.75 ± 0.4 mm
C2 8 ± 1.00 mm 16.2 ± 0.8 mm
C3 22.75 ± 0.4 mm 22.25 ± 1.06 mm
Active ingredients
Tween 80 0.00 16.0 ± 1.4 mm
Cremophor–EL 0.00 11.5 ± 0.7 mm
Transcutol P 0.00 7.5 ± 0.7 mm
α-linolenic acid (1 mM) 10.2 ± 0.6 7.5 ± 0.6
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3. Materials and Methods
3.1. Materials
Tween 80, Tween 20, Transcutol P, Cremophor EL, PEG 400 and α-linolenic acid were purchased
from Sigma (Sigma Aldrich, Dorset, UK). The derivatisation reagent, BCl3-methanol 12% w/w (12%
boron trichloride in methanol), n-hexane (HPLC grade, purity, ≥99%) were also purchased from
Sigma (Sigma Aldrich, Dorset, UK). Labrasol, Capryol 90 and Labrafil M2125 were kindly gifted from
Gattefosse Company (Bracknell, UK).
3.2. Microorganisms
Fresh cultures of N. gonorrhoeae strain NCCP11945 were grown on GC agar (Oxoid, Basingstoke,
UK) at 37 ◦C in an atmosphere of 5% CO2 for 24 h. The colonies were removed from the culture
plate with a loop and suspended into a 3 mL GC broth until cloudy. The culture was mixed well and
standard density was adjusted to 107 CFU per mL.
Fresh cultures of S. aureus strain NCTC06571 were grown on nutrient agar (Oxoid, Basingstoke,
UK) at 37 ◦C for 24 h. The colonies were removed from the culture plate with a loop and suspended
into a 3 mL Ringer solution until cloudy. The culture was mixed well and the standard density was
adjusted to 0.5 McFarland (1.5 × 108 CFU per mL).
3.3. Preformulation Studies
3.3.1. Excipient Selection (Surfactants & Co-Surfactants)
The selection of suitable excipients is essential in the development of microemulsion. Excipients
having maximum solubilizing potential for the fatty acid are selected for the formulation of the
α-linolenic acid based ME. Selection of excipients was done by reviewing the published literature.
Surveying the literature, a range of excipients was checked for use in ophthalmic preparations.
Tween 20, Tween 80, Cremophor EL, Capryol 90, Labrasol and Labrafil M2125 were selected as
surfactants and Transcutol P and PEG 400 were selected as co-surfactants.
3.3.2. Determination of Saturation Solubility of α-Linolenic Acid in Different Surfactants and
Co-Surfactants
The solubility of α-linolenic acid in various surfactants and co-surfactants was determined
using a 96 well plate method reported by Bharate et al. [50]. Stock solutions of fatty acid were
prepared in methanol (1 µg/mL to 1800 µg/mL). 250 µL of each of stock solution was transferred
into the 96-well plates and the solvent was evaporated then 250 µL of different surfactants and
co-surfactants was added into the wells and plates were shaken horizontally at 600 rpm for 5 h
at room temperature. The plates were then centrifuged at 3000 rpm for 15 min and then samples
were analysed by UV spectrophotometer at 350 nm. Each experiment was performed in triplicate.
The solubility of α-linolenic acid was also determined in different ratios of surfactant and co-surfactant
as 1:1, 1:4 and 4:1 using 96 well plate method reported above.
3.3.3. Selection of Surfactant & Co-Surfactant Blend
Based on the individual solubility studies, Tween 80 and Cremophor EL were selected as
surfactants and Transcutol P was selected as co-surfactant. The solubility of α-linolenic acid was also
determined in various surfactants and co-surfactants mixtures. The individual non-ionic hydrophilic
surfactant was blended with the selected co-surfactant in ratios of 1:1, 1:4 and 4:1 (w/w).
3.3.4. Construction of Pseudo-Ternary Phase Diagram
The pseudo-ternary phase diagrams were constructed to determine the concentration range of all
components (α-linolenic acid/surfactant/co-surfactant/water) in which they form a microemulsion.
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The surfactant and co-surfactant were mixed at 1:1 and 4:1 ratio. Different mixtures of α-linolenic
acid and surfactant/co-surfactant mixtures were prepared at weight ratios of 0:10, 0.5:9.5, 1:9, 2:8, 3:7,
4:6, 5:5, 6:4, 7:3, 8:2 and 9:1, respectively. The pseudo-ternary phase diagrams were constructed by
using the phase diagram by micro-plate dilution (PDMPD) method, a novel technique based on the
water titration method [51]. The microtitre plates were filled by pipette in accordance with the filling
scheme: The wells A1 to D5 were filled in two steps. Fatty acids/surfactants/co-surfactants mixture
was filled into the wells with 200 µL at the first well and down by increments of 5 µL to reach 0 µL.
Then, water was added to each well to make a final volume of 200 µL. After the plates had been filled,
they were sealed and then shaken for 24 h at room temperature (25 ◦C). After that, the microplates were
characterised by measuring absorbance using microplate reader at 600 nm and by making a visual
evaluation of the isotropy and the border between the homogeneous or the heterogeneous system.
The percentage of transmittance of the microemulsion formulations was determined using the
following formula, where T is transmittance and A is absorbance.
%T = antilog (A − 2) (2)
3.3.5. Preparation of Microemulsion Formulations
According to microemulsion region in the phase diagram, ME formulations were selected at
different component ratios. α-linolenic acid (ALA) was used as an oil phase. Tween 80 and Cremophor
EL were selected as surfactants. Transcutol P was selected as co-surfactant with water as aqueous phase.
Surfactant and co-surfactant were mixed at different mass ratios (1:1, 4:1). α-linolenic acid was
dissolved under stirring in mixture of S/CoS. Then, the appropriate amount of water was added to the
mixture drop by drop with continuous stirring.
3.3.6. Characterization of Microemulsions
Visual Evaluation
Microemulsions were first monitored for transparency, signs of phase separation and birefringence
with the aid of visual evaluation. Visual evaluation helps to differentiate between microemulsions and
other two phase systems such as emulsions. Visually microemulsions are transparent or translucent,
whereas emulsions are turbid.
After visual inspection, the formulations which have better clarity and no phase separation were
confirmed for selection as clarity of the formulation is the initial priority of the microemulsion [52].
Polarized Light Microscopy
Plane polarized light microscopy was used to distinguish between pure microemulsions and
microemulsions containing lamellar liquid crystals. ME samples were prepared by placing a drop of ME
between a coverslip and a glass slide and were then examined using cross-polarized light microscopy
(Polarizing Microscope RPL-55 Series, Radical Instruments, Ambala Cantt, India). The isotropic
and anisotropic behaviour of the samples was observed. Isotropic materials such as microemulsion,
in contrast to anisotropic liquid crystals, do not interfere with the polarized light and the field of view
remains dark because the analyser absorbs light passing through the polarizer.
Droplet Size and Zeta Potential Measurement
The droplet size, polydispersity index (PDI) and zeta potential (ZP) of MEs were measured by
dynamic light scattering using a Zetasizer (Malvern instruments Ltd., Malvern, UK). ME samples were
analysed in triplicate at 25 ◦C.
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Determination of pH
The pH values for microemulsions were determined at 25 ◦C by pH meter (JENWAY model 3305,
JENWAY Ltd., Stone, UK). All measurements were carried out in triplicate.
Viscosity Measurements
Viscosity of samples was measured at 25 ◦C with a Brookfield viscometer (DV-II+Pro Brookfield.,
Middleboro, MA 02346, USA) using spindle No. 34. With shear rate 50 rpm. Each measurement was
performed in triplicate.
Drug Content Determination
Concentration and drug content of FA-based ME formulations were determined using the Gas
Chromatography-Flame Ionization Detector (GC-FID) method [17]. ME samples were derivatised by
using BCl3-methanol (12% w/w) in a water bath at 60 ◦C for 8 min. Then, samples were extracted with
n-hexane (1–2 mL) by hand-shaking for 1 min until both layers were clear. The layers were allowed
to settle and the upper (organic) layer was transferred into a clean vial. The organic layer containing
fatty acid methyl esters (FAMEs) was dried by adding 500 mg of anhydrous sodium sulphate. Then,
samples were analysed by the GC-FID method [17].
Contact Angle Measurements
Contact angles of prepared microemulsions were measured with goniometer method [40]. A 5 µL
droplet of the microemulsion was placed on the surface of a plate and the image was immediately sent
via the CCD camera to the computer for analysis. Contact angles were determined as the cosine (θ) of
the contact angle (θ) between the ME droplet attached to the hydrophilic surface (dry glass slide) or
hydrophobic surface (glass slide covered with parafilm) and the droplet. For all tests, the mean value
of at least three replicate evaluations was reported.
3.3.7. Stability Studies
Physical and chemical stability testing of selected microemulsions were performed under the
accelerated conditions in triplicate (n = 3) to find out the stable microemulsions. For stability
testing, microemulsions were kept at various temperatures (4 ◦C, 25 ◦C and 40 ◦C) for 8 weeks.
The clarity, phase separation, particle size, zeta potential and drug content of tested microemulsions
were determined at 0, 1 week, 4 weeks and 8 weeks [53].
3.3.8. Self-Diffusion NMR
Self-diffusion NMR measurements were carried out at 600 MHz using a Bruker Avance DRX 600
(Billerica, MA, USA) at 25 ◦C. Each sample was dissolved in D2O (internal standard) and filled into
NMR tube. The self-diffusion coefficients of pure components were calculated. The self-diffusion
coefficients of components in the microemulsion samples were compared with those of the single
components to determine the type of microemulsion. The diffusion coefficients (D) were obtained
from the slope of the Stejskal-Tanner equation [54]:
ln
(
Ig
I0
)
= −[γ 2g2δ2
(
∆− δ
3
)
]D (3)
where Ig and I0 are intensities of the NMR signal in the presence and absence of field gradient pulses;
γ is the gyromagnetic constant for 1 H; g is the duration of the z-gradient pulse; δ is the gradient
strength; and ∆ is the time interval between the gradient pulses.
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3.3.9. Antibacterial Activity of MEs against N. gonorrhoea and S. aureus
The antimicrobial activity of prepared microemulsions and its individual components against N.
gonorrhoea and S. aureus were checked using disc diffusion method [17,18]. Blank paper discs (6 mm
diameter) were loaded with 10 µL of the microemulsion formulations and its individual components
and allowed to air-dry at room temperature. Nutrient agar plates were inoculated with bacterial
suspension by dipping a sterile cotton wool swab into the suspension and spreading the inoculum
evenly over the entire surface of the plates by swabbing in three directions. Plates were allowed to
dry before applying discs. Then, the discs containing the test agents were applied to the surfaces
of inoculated plates. Plates were inverted and incubated at 37 ◦C for 24 h to allow for bacterial
growth. Inhibition zone diameters were measured in millimetres. All measurements were carried out
in triplicate.
3.3.10. Ocular Irritation Testing
In this study, BCOP & HET-CAM tests were used to investigate the ocular irritation potential of
prepared microemulsions and their ingredients.
BCOP Test
Bovine’s eyes acquisition and examination. Bovine eyes were obtained from a local
slaughter house. The eyes were examined for epithelium detachment, corneal opacity and corneal
vascularization. Eyes with corneal damage or abnormalities were discarded.
Test substances. NaOH (0.5 M) was used as a positive control strong irritant, acetone as a
moderate irritant and normal saline as a negative control [46]. Microemulsions and all used ingredients
(α-linolenic acid, Tween 80, Cremophor EL and Transcutol P) were investigated for their corneal
irritation potential using BCOP test.
Irritation testing, scoring and classification. The eyes were held with small plastic cups (cornea
upwards) in the humid atmosphere of a closed water bath at 37 ◦C + 0.5 ◦C for 10 min. A silicon O-ring
was carefully placed on the central part of the cornea. One drop of saline was applied inside the ring
and eyes were equilibrated in a closed water bath for 5 min. Then the test substance was applied to
the cornea inside the ring at a volume of 0.1 mL. After 30 s, the eyes were rinsed with approximately
10 mL saline and further incubated in the closed water bath for 10 min. The extent of corneal injury
was assessed by evaluating the opacity. Then sodium fluorescein solution (2% w/v and pH 7.4) was
applied to the cornea and corneal permeability was assessed using examination lamp and cobalt blue
filter and following the scoring systems [46] in Table 3.
Table 3. Bovine eye scoring system.
Opacity Score Fluorescein Permeability Score Cumulative Score Interpretation
None 0 None 0 ≤0.5 None
Slight 1 Diffuse and weak 0.5 0.6–1.9 Slight
Marked 2 Confluent and weak 1 2.0–4.0 Moderate
Severe 3 Confluent and intense 1.5 >4 Severe
Opaque 4 - - - -
HET-CAM Test
Preparation of the CAMs. CAMs were prepared following the protocol early described by
Reference [18]. Briefly, freshly collected fertilised hen’s eggs were incubated at 37.5 ◦C ± 0.5 ◦C and
66% ± 5% relative humidity (RH) for 3 days. During incubation, eggs were turned by hand five times
per day to prevent the attachment of the embryo to one side of the egg. On day three, the eggshells
were opened by cracking the underside of the egg against the edge of a plastic Petri dish. The content
of the shell was then poured into a growing chamber. The growing chamber was made of a glass
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beaker over which a piece of cellophane membrane was attached and fixed in position using a circular
plastic sleeve. Once in the growing chamber, each egg was examined for the viability of the embryo
(intact CAM and yolk sac). Defective or non-viable eggs were discarded and only viable embryos with
intact CAMs and yolk sacs were further incubated [46,55].
NaOH (0.1 M) was used as a positive control strong irritant and normal saline as a negative control.
All prepared microemulsions and excipients; (Tween 80, Transcutol P, PEG 400, α-linolenic acid) were
tested for their ocular irritation potential.
Irritation testing, scoring and classification. On day 10, 0.2 mL of the test substances was placed
onto the CAM. For each test substance three eggs were used. After treatment with test substances,
the blood vessels and capillaries were examined for the irritant effects of hyperaemia, haemorrhage,
clotting and/or coagulation at different times post application [25,26]. A time dependent numerical
score was then allocated to each test compound or formulation. The sum of the time dependent
numerical scores for all three responses of hyperaemia, haemorrhage, clotting and/or coagulation
gives a single numerical value (Table 4). The mean value of four tests allows for the assessment by a
classification scheme similar to the Draize test [56].
Table 4. Irritation scores and interpretations used in HET-CAM test.
Score Cumulative Score Irritation Assessment
Effect 0.5 min 2 min 5 min 0–0.9 None
Hyperaemia 5 3 1 1.0–4.9 Slight
Haemorrhage 7 5 3 5.0–8.9 Moderate
Coagulation 9 7 5 9.0–21.0 Severe
3.3.11. Statistical Analysis
All the experiments were repeated three times and data were expressed as the mean value ± SD.
Statistical analysis was performed using the software Graphpad Prism (Graphpad Prism software, Inc.,
San Diego, CA, USA). Statistical data were analysed by one-way analysis of variance (ANOVA) and
Student’s t test. Differences were considered significant for p < 0.05.
4. Conclusions
In this study, fatty acid based microemulsions were prepared and evaluated. The selection of
surfactant and cosurfactants were selected after evaluating the saturation solubility of lineolenic acid
in different systems while Pseudo-ternary phase diagrams were constructed to evaluate the regions
of microemulsion. Nine different fatty acid-based microemulsions were prepared comprising of
α-linolenic acid as oil phase, Tween 80 and Cremophor EL as surfactant, Transcutol P as co-surfactant
and water as aqueous phase. The prepared microemulsions were characterized, showing an average
particle size around 250 nm and a pH of 5.5. The prepared ME formulations were isotropic colloidal
dispersions and did not show any lamellar and hexagonal liquid crystals when examined using
polarized light microscopy.
All ME formulations were stable upon storage for 8 weeks without significant change in particle
size and drug content as it is believed that the ME formulations protected the α-linolenic acid
from autoxidation. All MEs exerted strong antimicrobial effects against N. gonorrhoeae and S. aureus
without being irritant to the eye as suggested by the BCOP and HET-CAM studies. The study suggests
that α-linolenic acid ME can be used as an effective and stable therapy for treatment of ophthalmia
neonatorum conditions caused by Neisseria gonorrhoeae and Staphylococcus aureus.
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